Explore leading companies in the Life Sciences & BioTech category. Discover market leaders, emerging players, and innovative companies shaping this industry.
Filter by Tags
Available Tags
Agriculture
Ai Powered
Analytics
Api First
Asia Pacific
Automation
B2b
B2b2c
B2c
Cloud Native
Data Warehouse
Decacorn
Developer Tools
Energy
Enterprise
Europe
Fortune500
Global
Hardware
Healthtech
Infrastructure
Iot
Manufacturing
Marketplace
North America
Open Source
Platform
Public
Saas
Scaleup
Services
Startup
Supply Chain
Technology
Unicorn
Us Only
All Life Sciences & BioTech Brands
| Brand ↑ | Tags | Revenue | Market Share | Description |
|---|---|---|---|---|
| 10x Genomics | B2bGlobalPublicEnterpriseHealthtechHardwareAnalyticsPlatform | $642M | - | Leading single-cell genomics platform; $642M FY2025 revenue. Chromium and Visium spatial platforms power cell-type discovery in oncology, neuroscience... |
| AbCellera | B2bGlobalPublicHealthtechAi PoweredPlatformAnalytics | $75M | - | Vancouver-based antibody discovery platform with 104+ partner programs; $75M FY2025 revenue. Expanding into wholly owned assets with ABCL635 in Phase ... |
| Absci | Ai PoweredTechnologyStartupHealthtechPlatformPublicB2b | - | - | Absci is an AI drug creation company that combines generative AI with a synthetic biology platform to design novel therapeutic proteins from the groun... |
| Addition Therapeutics | HealthtechB2b | - | - | Emerged from stealth with $100M (Dec 2025) backed by Gates Foundation, SR One, Abingworth. PRINT LNP platform integrates RNA at specific genomic loci ... |
| Advanced Microbubbles | HealthtechStartupNorth AmericaB2bHardwareTechnology | - | - | Advanced Microbubbles develops ultrasound-activated microbubble technology for targeted drug and gene delivery, with a primary focus on oncology; micr... |
| Aerska Therapeutics | HealthtechB2b | - | - | Raised $39M (Feb 2026, doubled from $21M Series A). Brain-shuttle + RNAi delivery for genetic Alzheimer's and Parkinson's. Non-viral CNS delivery cros... |
| Aevice Health | HealthtechIotAi PoweredStartupB2b | - | - | Aevice Health raised $30M Series B in 2025 for its AI-powered wearable respiratory monitor that continuously tracks wheezing, coughing, and breathing ... |
| Agomab Therapeutics | HealthtechB2b | - | - | Nasdaq IPO Feb 2026 (~$200M raised, ~$780M valuation, ticker AGMB). Positive Phase 2a data for ontunisertib in fibrostenosing Crohn's. Phase 1 data fo... |
| Aignostics | B2bAi PoweredHealthtechEuropeStartupAnalyticsPlatformSaas | - | - | Aignostics is a Berlin-based computational pathology company applying AI to histopathology image analysis for drug development and clinical diagnostic... |
| Alamar Biosciences | B2bHealthtechAi PoweredHardwareStartupNorth AmericaAnalytics | - | - | Alamar Biosciences develops the NULISA proteomics platform for ultrasensitive protein biomarker detection from minimal sample volumes; enables early d... |
| Alto Neuroscience | HealthtechB2b | - | - | Nasdaq-listed (ANRO). Raised $120M PIPE (2026) to fund ALTO-207 Phase 2b. FDA Fast Track for ALTO-101. Biomarker-stratified psychiatry matching patien... |
| Altos Labs | HealthtechB2bStartupTechnologyGlobalNorth AmericaEuropeAnalytics | - | - | Altos Labs is a longevity biotech company focused on cellular rejuvenation programming to reverse disease and extend healthspan; raised $3B at launch ... |
| Alumis | B2bHealthtechStartupNorth AmericaPublicAnalytics | - | - | Alumis is a clinical-stage biopharmaceutical company developing oral TYK2 inhibitors for immune-mediated diseases including psoriasis, lupus, and infl... |
| Alveus Therapeutics | HealthtechTechnologyStartupB2bGlobal | - | - | Alveus Therapeutics raised $150M Series A in 2025 for inhaled mRNA therapeutics targeting pulmonary diseases including idiopathic pulmonary fibrosis a... |
| Alzheon | HealthtechStartupNorth AmericaB2bPlatform | - | - | Alzheon is a clinical-stage biotech developing ALZ-801, an oral amyloid oligomer inhibitor for Alzheimer's disease prevention in genetically at-risk p... |
| Amplitude Vascular Systems | B2bHealthtechHardwareStartupNorth AmericaTechnology | - | - | Amplitude Vascular Systems (AVS) is a medical device company developing the Pulse IVL system — a high-frequency pulsatile pressure wave device for tre... |
| Areteia Therapeutics | B2bHealthtechStartupNorth AmericaTechnology | - | - | Areteia Therapeutics (formerly TPI) is developing dexpramipexole, an oral eosinophil-depleting drug for eosinophilic asthma and EGPA; raised $215M in ... |
| Artiva Biotherapeutics | B2bHealthtechStartupNorth AmericaPublic | - | - | Artiva Biotherapeutics develops off-the-shelf allogeneic natural killer (NK) cell therapies for cancer; lead program AB-101 targets B-cell malignancie... |
| Asimov | B2bHealthtechAi PoweredDeveloper ToolsSaasStartupNorth AmericaAnalytics | - | - | Asimov develops software and AI tools for mammalian cell engineering to accelerate design and manufacturing of biologics and gene therapies; combines ... |
| Athos Therapeutics | HealthtechAi PoweredStartupEuropeB2bOpen Source | - | - | Athos Therapeutics is a UK clinical-stage biotech founded in 2019 using AI and systems biology to discover precision therapies for autoimmune and chro... |
| Atomic AI | HealthtechAi PoweredStartupNorth AmericaB2bAnalytics | - | - | Atomic AI is a San Francisco biotech using AI and structural biology to design RNA-targeting therapeutics; founded in 2021 by Raphael Townshend (Alpha... |
| Axtria | AnalyticsAi PoweredB2bSaasEnterpriseHealthtechCloud NativeGlobalPlatform | - | - | Axtria delivers AI-powered analytics and commercial software to 16 of the top 20 global life sciences companies; recognized in two Gartner Hype Cycle ... |
| Be Biopharma | HealthtechB2b | - | - | $274M total raised including $92M Series C with Bristol Myers Squibb. Phase 1/2 active for BE-101 in Hemophilia B. CRISPR-engineered B cells as contin... |
| Beam Therapeutics | StartupTechnologyHealthtechPublicB2b | - | - | Beam Therapeutics develops precision genetic medicines using base editing technology that makes single-letter DNA changes without cutting the double h... |
| Beckley Psytech | HealthtechStartupB2bTechnologyEurope | - | - | Beckley Psytech (now AtaiBeckley) achieved FDA Breakthrough Therapy Designation for BPL-003 (5-MeO-DMT nasal spray) for treatment-resistant depression... |
| BenchSci | B2bAi PoweredHealthtechSaasPlatformAnalyticsStartupScaleupNorth AmericaEnterprise | - | - | BenchSci is an AI-powered biomedical research intelligence platform used by 16 of the top 20 pharma companies; accelerates experiment design by analyz... |
| BillionToOne | HealthtechAi PoweredPublicNorth AmericaB2bPlatform | - | - | IPO Nov 2025 (BLLN, Nasdaq); $273M raised; 508K+ tests in 2025; $293–299M revenue guidance FY2025.... |
| BioAge Labs | HealthtechB2bPublicNorth AmericaStartup | - | - | Clinical-stage biotech targeting metabolic aging for obesity and muscle-wasting disorders. IPO Sep 2024 (Nasdaq: BIOA); $198M raised; lead program aze... |
| BioNTech | B2bGlobalPublicEnterpriseHealthtechManufacturingPlatform | - | - | German mRNA pioneer co-developed COVID-19 vaccine with Pfizer; 20+ clinical programs in oncology and infectious disease;... |
| bit.bio | B2bHealthtechPlatformStartupEuropeTechnologyOpen Source | - | - | bit.bio is a Cambridge, UK synthetic biology company using its proprietary opti-ox technology to reprogram stem cells into any human cell type at scal... |
| Bluejay Therapeutics | HealthtechB2bNorth AmericaStartupScaleupAsia Pacific | - | - | Bluejay Therapeutics is a clinical-stage biopharmaceutical company developing therapies for chronic hepatitis B and liver diseases; raised over $100M;... |
| BostonGene | B2bHealthtechAi PoweredAnalyticsEnterprise | - | - | BostonGene is an AI-powered precision oncology company using multiomics and tumor microenvironment analysis to guide cancer treatment; won Frost & Sul... |
| BrightHeart | HardwareHealthtechB2b | - | - | Raised €11M Series A (Jan 2026). FDA-cleared in 2025. Detects 96%+ of congenital heart defects in prenatal ultrasound. Distributed via GE HealthCare V... |
| C16 Biosciences | B2bStartupNorth AmericaTechnologyAgricultureSupply ChainEnergy | - | - | C16 Biosciences produces Palmless, a biofermentation-derived alternative to palm oil targeting the beauty, personal care, and food industries; raised ... |
| Caidya | B2bHealthtechGlobalEnterpriseServicesAsia PacificNorth AmericaScaleup | - | - | Caidya is a global mid-sized CRO formed from the merger of dMed Global and Clinipace; operates in 20+ countries across 50+ regions; raised $165M from ... |
| Cambrian Bio | HealthtechStartupB2bNorth AmericaPlatformSaas | - | - | Cambrian Bio is a New York-based clinical-stage biopharmaceutical company founded in 2019 that develops therapeutics targeting the biology of aging; o... |
| Capstan Therapeutics | HealthtechB2bStartupNorth AmericaAi PoweredPlatformHardware | - | - | Capstan Therapeutics develops in vivo RNA-based therapies using targeted lipid nanoparticles to engineer immune cells inside the body without ex vivo ... |
| Cellanome | HealthtechB2bStartupNorth AmericaHardwareAnalyticsPlatformAi Powered | - | - | Cellanome is building a multi-omics platform combining genome sequencing, microfluidics, and integrated sensors to measure biological data at single-c... |
| Cellares | B2bHealthtechHardwareManufacturingStartupGlobalNorth AmericaEuropeAsia Pacific | - | - | Cellares is the first Integrated Development and Manufacturing Organization (IDMO) for cell therapy, automating end-to-end CAR-T and cell therapy prod... |
| Cerevance | B2bB2cHealthtechStartupNorth AmericaScaleup | - | - | Cerevance is a CNS drug discovery company using proprietary NETSseq single-nucleus transcriptomics to identify cell-type-specific drug targets in huma... |
| ChromaCode | HealthtechAi PoweredAnalyticsB2bPlatformTechnologySaasStartupGlobal | - | - | ChromaCode develops HDPCR technology enabling standard PCR instruments to run highly multiplexed molecular diagnostic assays for infectious disease, o... |
| Circle Pharma | B2bHealthtechTechnologyNorth AmericaStartupScaleup | - | - | Circle Pharma develops orally deliverable macrocycle drug candidates targeting intracellular protein-protein interactions in cancer; raised $90M Serie... |
| Clasp Therapeutics | HealthtechB2bStartupTechnologyNorth America | - | - | Clasp Therapeutics develops tumor-specific T cell engagers targeting mutant p53 and other cancer driver mutation peptides presented by HLA molecules, ... |
| Cognito Therapeutics | HardwareHealthtechB2b | - | - | Raised $105M oversubscribed Series C (Mar 2026) led by Morningside Ventures. HOPE pivotal trial fully enrolled. Non-pharmacological Alzheimer's device... |
| Colossal Biosciences | StartupB2bAnalyticsAi PoweredNorth AmericaDecacorn | - | - | Colossal Biosciences is the world's first de-extinction company; $555M raised, $10.2B decacorn valuation; targeting woolly mammoth embryos by 2026, di... |
| ConcertAI | HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn | - | - | ConcertAI is an oncology AI and real-world data company at a $1.9B valuation — 5.5M multi-modal cancer RWD records, $230M+ raised, exiting FY2024 prof... |
| Cornerstone Robotics | HardwareHealthtechB2b | - | - | Raised $200M oversubscribed (Nov 2025) backed by Hong Kong Investment Corporation and sovereign wealth funds. China NMPA-approved. UK colorectal/urolo... |
| Cradle | HealthtechSaasNorth AmericaB2b | - | - | AI protein design platform combining language models with lab automation; active learning cycles for enzyme, antibody, and therapeutic protein enginee... |
| Cradle Bio | Ai PoweredStartupB2bSaasTechnologyHealthtech | - | - | Cradle provides an AI platform for protein engineering that accelerates the design of improved enzymes, antibodies, and other biologics for industrial... |
| CUTISS | B2bB2cHealthtechStartupEuropeScaleup | - | - | CUTISS is a Swiss biotech developing personalized dermo-epidermal skin grafts from patient cells for large skin defect treatment; denovoSkin product r... |
| Cytogel Pharma | HealthtechStartupNorth AmericaB2b | - | - | Cytogel Pharma is a clinical-stage biotech developing CYT-1010, a first-in-class endomorphin-based analgesic for non-addictive pain relief; targets th... |
| Cytotheryx | HealthtechB2b | - | - | Raised $60M Series A (Jan 2026) led by Ouroboros Capital. Mayo Clinic spinout. Engineered pigs as bio-incubators for human hepatocyte production at sc... |
| Deep Genomics | B2bAi PoweredStartupNorth AmericaTechnologyAnalyticsPlatformHealthtech | - | - | Deep Genomics uses AI to discover and design RNA-based therapies for genetic diseases; its AI Workbench platform decodes RNA biology at scale; raised ... |
| Delfi Diagnostics | B2bHealthtechAi PoweredAnalyticsNorth AmericaStartupTechnology | - | - | Delfi Diagnostics has raised $332M total to develop blood-based cancer detection using whole-genome cfDNA fragmentation analysis and ML; clinically va... |
| Detect | HealthtechB2cB2bHardwareNorth AmericaTechnologyAi Powered | - | - | Detect pioneered the FDA-authorized rapid at-home molecular COVID-19 test and is now developing a second-gen molecular diagnostics platform targeting ... |
| Dewpoint Therapeutics | B2bHealthtechAi PoweredStartupNorth AmericaAnalytics | - | - | Dewpoint Therapeutics pioneers drug discovery targeting biomolecular condensates — liquid-like protein assemblies implicated in cancer, neurodegenerat... |
| Disc Medicine | B2bB2cHealthtechStartupNorth AmericaPublic | - | - | Disc Medicine is a Nasdaq-listed clinical-stage biopharma focused on hematologic diseases including polycythemia vera and myelofibrosis; lead asset bi... |
| DNA Script | B2bHealthtechHardwareEuropeGlobalStartupTechnologyManufacturing | - | - | DNA Script has raised $335M total including a $165M oversubscribed Series C; received CE Mark in 2025 for SYNTAX System in clinical labs across Europe... |
| DNAnexus | B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure | - | - | DNAnexus is the leading precision health data cloud, managing 65+ petabytes of biomedical data for 12,000+ users across 48 countries; $200M Series I l... |
| Dotmatics | - | - | - | Dotmatics (acquired by Insightful Science 2024) serves 1M+ researchers at 10,000+ organizations; R&D data management and scientific informatics platfo... |
| Dyno Therapeutics | B2bHealthtechAi PoweredStartupNorth AmericaAnalytics | - | - | Dyno Therapeutics uses AI and high-throughput synthesis to engineer next-generation AAV gene therapy vectors with improved tissue targeting, manufactu... |
| Earendil Labs | HealthtechB2b | - | - | Full-stack AI biologics company raised $787M in Mar 2026 backed by Sanofi, Pfizer/Hillhouse, and DST Global; $2.56B Sanofi collaboration signed Jan 20... |
| eGenesis | HealthtechB2b | - | - | FDA-cleared IND for CRISPR-edited pig kidney (ESKD Phase 1/2/3). First patient dialysis-free at 7+ months post-transplant. 69-gene-edited pig — most c... |
| Eikon Therapeutics | HealthtechB2b | - | - | Raised $381M IPO on Nasdaq (Feb 2026, EIKN). Proprietary RESOLFT super-resolution microscopy tracks single protein molecules in living cells. Creates ... |
| Element Biosciences | B2bHardwarePlatformNorth AmericaAnalyticsGlobalScaleupAi Powered | - | - | Element Biosciences makes the AVITI benchtop DNA sequencer; raised $277M Series D in 2024 (led by Wellington Management, Samsung) for $680M+ cumulativ... |
| Elligo Health Research | B2bHealthtechPlatformSaasNorth AmericaStartupAnalyticsAi Powered | - | - | Elligo Health Research brings clinical trials into healthcare settings by using EHR data for patient identification and providing site infrastructure;... |
| Emerald Cloud Lab | B2bSaasCloud NativePlatformAutomationApi FirstOpen SourceAi PoweredNorth America | $15M | - | Emerald Cloud Lab offers a fully remote, cloud-controlled laboratory with 200+ instrument models; ~$15M ARR as of 2025 with labs in the U.S. and expan... |
| Emulate | HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America | - | - | Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system ... |
| Encapsulate Bio | HealthtechB2bStartupNorth AmericaAi Powered | - | - | Encapsulate Bio develops tumor-on-a-chip microfluidic platforms that test patient-derived tumor samples against cancer therapies to guide personalized... |
| Endeavor Biomedicines | B2bHealthtechStartupNorth America | - | - | Endeavor Biomedicines is a Cambridge-based clinical-stage biotech targeting drivers of fibrosis and oncology with precision small molecules; raised $4... |
| Enterprise Therapeutics | B2bHealthtechEuropeStartup | - | - | Enterprise Therapeutics is a UK-based drug discovery biotech targeting ion channels and mucus biology to treat cystic fibrosis, COPD, and non-CF bronc... |
| Enveda Biosciences | B2bHealthtechAi PoweredStartupNorth AmericaScaleup | - | - | Enveda Biosciences uses AI, metabolomics, and robotics to mine natural products for novel drug candidates; platform identifies chemical structure and ... |
| EpiBiologics | HealthtechB2b | - | - | Raised $107M Series B (Jan 2026) co-led by J&J Ventures and Google Ventures. EpiTAC targets membrane and secreted proteins — expanding degradation bey... |
| ET Healthcare | B2bHealthtechHardwareStartupNorth America | - | - | ET Healthcare develops isotachophoresis (ITP) technology for rapid, automated nucleic acid and biomarker sample preparation in life sciences research ... |
| Evolved by Nature | B2bHealthtechManufacturingAgricultureStartupNorth AmericaPlatform | - | - | Evolved by Nature has developed Activated Silk technology — a green chemistry platform using natural silk proteins as sustainable, high-performance in... |
| Evozyne | B2bStartupAi PoweredTechnologyNorth AmericaHealthtech | - | - | Evozyne applies generative AI and evolutionary principles to design novel therapeutic proteins; raised $144M total including $81M Series B led by Fide... |
| Finch Therapeutics | StartupHealthtechTechnologyPublicB2b | - | - | Finch Therapeutics develops microbiome-based medicines targeting the gut-brain and gut-immune axis with programs in autism spectrum disorder and C. di... |
| Florence Healthcare | B2bSaasHealthtechEnterprisePlatformGlobalCloud NativeAnalytics | - | - | Florence Healthcare is the leading clinical trial site enablement platform, connecting 12,000+ research sites in 45 countries; $116M raised from Insig... |
| FogPharma | StartupHealthtechNorth AmericaTechnology | - | - | FogPharma develops cell-penetrating mini-proteins (CPMPs) to target intracellular cancer drivers like beta-catenin and FOXM1 that are undruggable by a... |
| Formation Bio | B2bHealthtechAi PoweredEnterpriseSaasPlatformNorth AmericaScaleupStartup | - | - | Formation Bio is an AI-native pharmaceutical company that acquires clinical-stage drug assets and accelerates their development to market using propri... |
| ForSight Robotics | HardwareHealthtechB2b | - | - | Ophthalmic robotics company raised $125M Series B in Jun 2025; first human cataract trials launching 2026;... |
| Freenome | HealthtechAi PoweredB2bB2cNorth AmericaStartupPlatformAnalytics | - | - | Freenome is a biotech company developing AI-powered multiomics blood tests for early cancer detection; raised $1.1B+ total with Roche as a major inves... |
| Frontier Bio | B2bStartupHealthtechNorth AmericaAi Powered | - | - | Frontier Bio develops living vascular grafts and bioprinted human tissue for pharmaceutical testing and future organ donation, using a 4D self-assembl... |
| Frontier Medicines | B2bHealthtechAi PoweredStartupNorth AmericaScaleupPlatformTechnology | - | - | Frontier Medicines is a precision medicine biotech targeting previously undruggable disease-causing proteins using chemoproteomics and covalent chemis... |
| Gameto | HealthtechTechnologyStartupB2bGlobal | - | - | Gameto raised $70M Series B in 2024 for its stem cell technology that dramatically reduces IVF stimulation duration from 10 days to 2–3 days, making f... |
| GATC Health | B2bAi PoweredHealthtechAnalyticsPlatformNorth AmericaStartupSaas | - | - | GATC Health uses its Multiomics Advanced Technology (MAT) platform to simulate human biochemistry and accelerate drug discovery; its AI achieves 86% s... |
| Genentech | B2bGlobalEnterprisePublicHealthtechManufacturingFortune500 | - | - | Roche subsidiary and founding biotech; invented the biologics industry with recombinant DNA. Blockbuster oncology franchise includes Herceptin, Avasti... |
| Genesis Therapeutics | B2bAi PoweredHealthtechNorth AmericaStartupPlatformAnalytics | - | - | Genesis Therapeutics (now Genesis Molecular AI) is a biotech company applying AI to small molecule drug discovery; raised $200M Series B in 2025 led b... |
| GenScript ProBio | B2bHealthtechAsia PacificGlobalEnterpriseManufacturingPlatformTechnology | - | - | GenScript ProBio is the CDMO subsidiary of GenScript Biotech, offering gene synthesis, biologics development, cell therapy manufacturing (CAR-T), and ... |
| HeartFlow | HealthtechAi PoweredB2bPublicTechnologyPlatform | - | - | HeartFlow creates AI-powered, non-invasive 3D models of coronary arteries from CT scans to guide treatment of coronary artery disease, with FDA cleara... |
| Hemab Therapeutics | HealthtechB2b | - | - | Raised $157M oversubscribed Series C (Oct 2025) led by Sofinnova and Qatar Investment Authority. Sutacimig entering registration study 2026 for Glanzm... |
| Huisheng Pharmaceutical | HealthtechManufacturingAsia PacificB2bB2cServicesGlobal | - | - | Huisheng Pharmaceutical is a Chinese pharma company specializing in traditional Chinese medicine and modern drug formulations; operates across R&D, ma... |
| Illumina | B2bGlobalPublicEnterpriseHealthtechAnalyticsHardwarePlatformFortune500 | $4.34B | 80% | World's dominant DNA sequencing platform with ~80% market share; ~$4.34B FY2025 revenue. Powers clinical genomics, oncology diagnostics, and populatio... |
| ImmunoVec | HealthtechB2b | - | - | Received up to $40.7M ARPA-H award (Oct 2025). Polymeric nanoparticle platform to reprogram immune cells in vivo without viral vectors. Non-viral deli... |
| INBRAIN Neuroelectronics | HealthtechHardwareStartupEuropeB2bAi PoweredTechnology | - | - | INBRAIN Neuroelectronics develops graphene-based brain-computer interfaces for AI-driven, adaptive neuromodulation; raised €30M Series B in 2024; targ... |
| Inceptive | B2bHealthtechAi PoweredStartupEuropeNorth AmericaAnalytics | - | - | Inceptive designs synthetic RNA molecules for therapeutic applications using deep learning and high-throughput experiments; targets mRNA medicines, RN... |
| Infant Bacterial Therapeutics | HealthtechTechnologyStartupB2bPublic | - | - | Infant Bacterial Therapeutics (IBT) is developing live biotherapeutic Lactobacillus reuteri DSM17938 for necrotizing enterocolitis prevention in prema... |
| Insilico Medicine | B2bHealthtechSaasPublic | $56.2M | - | Insilico Medicine (HKEX: 3696) raised $293M, posted $56.2M revenue in 2025, and inked a $2.75B Eli Lilly deal in 2026 using generative AI to discover ... |
| Insitro | Ai PoweredStartupTechnologyAnalyticsHealthtechB2b | - | - | Drug discovery company founded by Daphne Koller integrating ML with high-throughput biology; raised $400M+ to build proprietary biological datasets fo... |
| InterVenn Biosciences | HealthtechAi PoweredB2bStartupAnalyticsNorth America | - | - | InterVenn Biosciences pioneered clinical glycoproteomics with AI-powered liquid biopsy diagnostics for cancer; raised $251M total, received AMA PLA co... |
Total Brands
198
Signal Strength
56% Strong
110871
Last Updated
September 2026